Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors — Stella

Home/Solid Tumors/A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors

View on ClinicalTrials.gov

Recruiting

Back to Solid Tumors trials

A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong

Key details

Phase

Early testing

Sponsor

Guangzhou Virotech Pharmaceutical Co., Ltd.

Collaborators

Third Affiliated Hospital, Sun Yat-Sen University

Enrollment target

~12 participants

Started

March 2025

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.